L

Ligand Pharmaceuticals

D
LGND
USD
18.7
(16.8408%)
Market Closed
7,401.00
Volume
4.19
EPS
-
Div Yield
55.682
P/E
2,370,213,573.00
Market Cap
Today
16.8408%
1 Week
22.558%
1 Month
26.378%
6 Months
76.854%
12 Months
143.918%
Year To Date
81.505%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
VRTX
VRTX
9.22
(1.869%)
USD
I
INCY
2.2
(2.7445%)
USD
J
JAZZ
7.635
(6.8528%)
USD
A
AGIO
3.39
(6.5698%)
USD
A
ACAD
1.42
(8.993%)
USD
ALNY
ALNY
-0.795
(-0.2913%)
USD
B
BLUE
-0.0729
(-16.2614%)
USD
N
NBIX
-1.26
(-1.0054%)
USD
I
ICPT
(%)
USD

Title:
Ligand Pharmaceuticals

Sector:
Healthcare
Industry:
Biotechnology
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license andmilestone payments, and sale of its trademarked Captisol material.
Do you need help or have a question?
Contact Us